These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. Urakami Y; Okuda M; Masuda S; Saito H; Inui KI J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712 [TBL] [Abstract][Full Text] [Related]
8. Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules. Groves CE; Suhre WB; Cherrington NJ; Wright SH J Pharmacol Exp Ther; 2006 Feb; 316(2):743-52. PubMed ID: 16249371 [TBL] [Abstract][Full Text] [Related]
9. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1. Li L; Song F; Tu M; Wang K; Zhao L; Wu X; Zhou H; Xia Z; Jiang H Int J Pharm; 2014 Apr; 465(1-2):5-10. PubMed ID: 24530383 [TBL] [Abstract][Full Text] [Related]
10. Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. Ishiguro N; Saito A; Yokoyama K; Morikawa M; Igarashi T; Tamai I Drug Metab Dispos; 2005 Apr; 33(4):495-9. PubMed ID: 15640376 [TBL] [Abstract][Full Text] [Related]
11. Functional influence of N-glycosylation in OCT2-mediated tetraethylammonium transport. Pelis RM; Suhre WM; Wright SH Am J Physiol Renal Physiol; 2006 May; 290(5):F1118-26. PubMed ID: 16368738 [TBL] [Abstract][Full Text] [Related]
12. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+. Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587 [TBL] [Abstract][Full Text] [Related]
13. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure. Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877 [TBL] [Abstract][Full Text] [Related]
14. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP. Schlatter E; Mönnich V; Cetinkaya I; Mehrens T; Ciarimboli G; Hirsch JR; Popp C; Koepsell H J Membr Biol; 2002 Oct; 189(3):237-44. PubMed ID: 12395288 [TBL] [Abstract][Full Text] [Related]
15. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032 [TBL] [Abstract][Full Text] [Related]
16. Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport. Soodvilai S; Chatsudthipong A; Chatsudthipong V Am J Physiol Renal Physiol; 2007 Jul; 293(1):F21-7. PubMed ID: 17327500 [TBL] [Abstract][Full Text] [Related]
17. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant. Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842 [TBL] [Abstract][Full Text] [Related]
18. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection. Jung N; Lehmann C; Rubbert A; Knispel M; Hartmann P; van Lunzen J; Stellbrink HJ; Faetkenheuer G; Taubert D Drug Metab Dispos; 2008 Aug; 36(8):1616-23. PubMed ID: 18490433 [TBL] [Abstract][Full Text] [Related]
19. The basolateral organic cation transport system of rabbit kidney proximal tubules. Influence of anorganic anions. Hohage H; Querl IU; Mörth DM; Greven J J Pharmacol Exp Ther; 1996 Dec; 279(3):1086-91. PubMed ID: 8968328 [TBL] [Abstract][Full Text] [Related]
20. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]